Companies›Financial Services›Financial Services›Finance

TITAN SECURITIES LTD.

Financial Services › Finance
₹35.50
at close · 27 Oct 2026
▲ 1.72 (+5.09%)

Latest filings

  1. RTA compliance certificate for Q2 FY27 dematerialisation · Compliance
  2. Titan Securities 34th AGM: All 5 resolutions passed with near-unanimous support · Board & Shareholder Meetings
  3. 34th AGM held via video conferencing; 5 resolutions tabled including borrowing and RPT · Board & Shareholder Meetings
All filings ↓
Ask Nexa about TITAN SECURITIES LTD.

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Operates as a non-banking financial company (NBFC) listed on the BSE, classified under the Financial Services industry. On a standalone basis, its own NBFC operations generated Rs. 596.32 lakh of revenue in FY26, down sharply from Rs. 1,045.84 lakh in FY25, with standalone profit after tax of Rs. 83.55 lakh. The standalone business carries no materials cost; employee costs and other operating expenses are each 3.4% of revenue and depreciation is 0.4%, reflecting a light-cost financial intermediary structure. The bulk of consolidated earnings comes from the company's equity stakes in two associates, Titan Biotech Ltd and Peptech Biosciences Ltd, which contributed Rs. 1,162.02 lakh as share of profit in FY26. Consolidated profit after tax for FY26 was Rs. 1,245.57 lakh, with total assets of Rs. 106.48 crore on the balance sheet. The CFO, Mrs. Darshana Santoshi, resigned effective May 30, 2026 for personal reasons, and the company has stated it is searching for a replacement. The associate-driven nature of consolidated earnings is a defining feature: in Q3 FY26 too, Rs. 329.30 lakh of the Rs. 367.18 lakh consolidated PAT came from Titan Biotech and Peptech Biosciences.

Operating scale
Listed exchange
BSE
Classification
Non-Banking Financial Company (NBFC)
Total assets
Rs. 106.48 croreFY26
FY26 standalone revenue
Rs. 596.32 lakhFY26
FY26 share of profit from associates
Rs. 1,162.02 lakhFY26
Associate companies
Titan Biotech Ltd, Peptech Biosciences Ltd
Who pays it
Borrowers/clients of its standalone NBFC operations; consolidated earnings largely depend on associates Titan Biotech and Peptech Biosciences
Biggest cost
No materials cost; main standalone costs are employee expenses and other operating expenses (each 3.4% of revenue)
Kind of business
Small NBFC holding company whose consolidated profit is dominated by associate-company earnings rather than its own lending or financial services book
Where it sits
A small BSE-listed NBFC whose standalone revenue declined 43% YoY in FY26, while consolidated earnings are driven primarily by equity stakes in Titan Biotech Ltd and Peptech Biosciences Ltd
Market Cap
₹89 Cr
P / E (TTM)
6.2×
EV / EBITDA
—
Div Yield
—
Growth
-33.9%▼
Revenue 5y CAGR
PAT +4.0% · EBITDA +3.7%
Quality
—·
ROCE (FY26)
ROE 11.7% (5y median) · margin 20.3%
Leverage
—·
Debt / Equity · not read for a lender
Revenue FY21→FY26
0.1×▼
Margin +187.2 pts
₹47 Cr → ₹6 Cr
Moves on a normal day
1.37%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 272 Non Banking Financial Company (NBFC) peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#31/200
P/B#106/253
ROE#40/257
EBITDA margin#192/249
Revenue growth#185/231
Profit growth#78/251

Scorecard

Measured from the filed financials, judged against its Non Banking Financial Company (NBFC) peers · as of FY26 — not investment advice

Strengths
Nothing stands out in the filed numbers.
Concerns
Revenue shrinking over 5 years (−34% a year)

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from TITAN SECURITIES LTD.'s filed financials and exchange disclosures

What does TITAN SECURITIES LTD. do?

TITAN SECURITIES LTD. is a Finance company listed on BSE.

Is TITAN SECURITIES LTD. profitable?

Yes. Over the trailing twelve months TITAN SECURITIES LTD. reported a net profit of ₹14 Cr on revenue of ₹5.59 Cr.

Does TITAN SECURITIES LTD. pay a dividend?

Not in the latest reported year — TITAN SECURITIES LTD.'s dividend payout for FY26 was nil.

Is TITAN SECURITIES LTD. expensive compared with its peers?

On trailing P/E, TITAN SECURITIES LTD. ranks 31 of 200 in Non Banking Financial Company (NBFC) — cheaper than 85% of them, against an industry median of 18.5×. This is a position, not a valuation judgement.

How much does the TITAN SECURITIES LTD. share price move in a day?

On a typical session TITAN SECURITIES LTD. moves 1.37% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

Where can I track TITAN SECURITIES LTD.'s announcements?

Every NSE and BSE filing by TITAN SECURITIES LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.